A case of ketamine dependence with discontinuation symptoms

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · see citing works

The Excitatory Amino Acid Receptors: Their Classes, Pharmacology, and Distinct Properties in the Function of the Central Nervous System

Monaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,193 · see citing works

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans

Krystal, J. H., Karper, L. P., Bennett, A., D’Souza, D. C., Abi‐Dargham, A., Morrissey, K., Abi‐Saab, D., Bremner, J. D., Bowers, M. B., Suckow, R. F., et al. (1998) · Psychopharmacology · doi:10.1007/s002130050503 · Cited by 184 · see citing works

The Nonmedical Use of Ketamlne, Part Two: A Review of Problent Use and Dependence

Jansen, K. L. R., & Darracot-Cankovic, R. (2001) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2001.10400480 · Cited by 137 · see citing works

Illicit Use of Ketamine in Scotland

Dalgarno, P., & Shewan, D. (1996) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1996.10524391 · Cited by 133 · see citing works

A Brief Overview of the Clinical Pharmacology of “Club Drugs”

Britt, G. C., & McCance‐Katz, E. F. (2005) · Substance Use & Misuse · doi:10.1081/ja-200066730 · Cited by 98 · see citing works

Ketamine Dependence

Pal, H. R., Berry, N., Kumar, R., & Ray, R. (2002) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0203000323 · Cited by 87 · see citing works

A case of ketamine dependence

(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.5.779a · Cited by 49 · see citing works

Interaction between ketamine and ethanol in rats and mice.

Fidecka, S., & Langwiński, R. (1990) · PubMed · Cited by 14 · see citing works

Ketamine use: a review

Morgan, C. J. A., Curran, H. V., & the Independent Scientific Committee on Drugs (ISCD) (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03576.x · Cited by 667 · see citing works

Side-effects associated with ketamine use in depression: a systematic review

Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30272-9 · Cited by 558 · see citing works

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

Williams, N. R., Heifets, B. D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., Hawkins, J., Birnbaum, J., Lyons, D. M., Rodriguez, C. I., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020138 · Cited by 519 · see citing works

Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications

Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265 · see citing works

Journey through the K-hole: Phenomenological aspects of ketamine use

Muetzelfeldt, L., Kamboj, S. K., Rees, H., Taylor, J., Morgan, C. J. A., & Curran, H. V. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.01.024 · Cited by 246 · see citing works

Ketamine

Bokor, G., & Anderson, P. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014525754 · Cited by 165 · see citing works

Legal highs: staying on top of the flood of novel psychoactive substances

Baumeister, D., Tojo, L. M., & Tracy, D. K. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314559539 · Cited by 160 · see citing works

KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE

Bobo, W. V., Voort, J. L. V., Croarkin, P. E., Leung, J. G., Tye, S. J., & Frye, M. A. (2016) · Depression and Anxiety · doi:10.1002/da.22505 · Cited by 122 · see citing works

Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development

Lerner, A., & Klein, M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz025 · Cited by 89 · see citing works

Gender differences in subjective discontinuation symptoms associated with ketamine use

Chen, W.-Y., Huang, M.-C., & Lin, S.-K. (2014) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/1747-597x-9-39 · Cited by 87 · see citing works

Ketamine-like Effects After Recreational Use of Methoxetamine

Hofer, K. E., Grager, B., Müller, D. M., Rauber‐Lüthy, C., Kupferschmidt, H., Rentsch, K., & Ceschi, A. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.11.018 · Cited by 87 · see citing works

Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant

Kokane, S. S., Armant, R. J., Bolaños‐Guzmán, C. A., & Perrotti, L. I. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112548 · Cited by 62 · see citing works

Constructions of Risk and Harm in Online Discussions of Ketamine Use

Tacket-Gibson, M. (2008) · Addiction Research & Theory · doi:10.1080/16066350801983699 · Cited by 53 · see citing works

Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.

Abdulrahim, D., & Bowden‐Jones, O. (2015) · Cited by 46 · see citing works

Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing

Swainson, J., Klassen, L. J., Brennan, S., Chokka, P. R., Katzman, M. A., Tanguay, R. L., & Khullar, A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00897-2 · Cited by 47 · see citing works

1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances

Wallach, J. V., & Brandt, S. D. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_148 · Cited by 42 · see citing works

Overdoses and deaths related to the use of ketamine and its analogues: a systematic review

Chaves, T. V., Wilffert, B., & Sanchez, Z. M. (2022) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2022.2132506 · Cited by 39 · see citing works

Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls

Wang, L., Chen, C., Lin, S., Chen, Y., Xu, K., & Huang, M. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4910-z · Cited by 37 · see citing works

Association of Craving and Depressive Symptoms in Ketamine‐Dependent Patients Undergoing Withdrawal Treatment

Chen, L., Chen, C., Chen, C., Chang, H., Huang, M., & Xu, K. (2020) · The American Journal on Addictions · doi:10.1111/ajad.12978 · Cited by 33 · see citing works

Psychedelics and dissociative substances

WINSTOCK, A. R., & Rucker, J. (2020) · doi:10.1093/med/9780198713005.003.0054 · Cited by 29 · see citing works

Potential benefit of lamotrigine in managing ketamine use disorder

Huang, M., Chen, L., Chen, C., & Lin, S. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.11.011 · Cited by 28 · see citing works

Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions

Vines, L., Sotelo, D., Johnson, A., Dennis, E., Manza, P., Volkow, N. D., & Wang, G. (2022) · Intelligent Medicine · doi:10.1016/j.imed.2022.03.001 · Cited by 26 · see citing works

Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review

Fluyau, D., Revadigar, N., & Pierre, C. G. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107845 · Cited by 22 · see citing works

Decreased Blood Levels of Oxytocin in Ketamine-Dependent Patients During Early Abstinence

Huang, M., Chen, L., Chang, H., Liang, X., Chen, C., Cheng, W., & Xu, K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00633 · Cited by 21 · see citing works

Reliability, convergent and structural validity and cut-off score of the Severity of Dependence Scale for recreational ketamine users

Fernández‐Calderón, F., Giné, C. V., López-Guerrero, J., & Lozano, O. M. (2016) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.03.016 · Cited by 21 · see citing works

Intensive ketamine use for multiple years: A case report

Liu, J. X., Zerbo, E. A., & Ross, S. (2015) · American Journal on Addictions · doi:10.1111/ajad.12153 · Cited by 18 · see citing works

Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation

Huang, M., Chen, C.-H., Chen, L., Chang, H., Chen, C.-K., Lin, S., & Xu, K. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05342-9 · Cited by 17 · see citing works

The Pharmacological Management of Ketamine Use Disorder: A Systematic Review

Roberts, E., Sanderson, E., & Guerrini, I. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001340 · Cited by 15 · see citing works

Abuse liability of centrally acting non-opioid analgesics and muscle relaxants – a brief update based on a comparison of pharmacovigilance data and evidence from the literature

Gahr, M., Freudenmann, R. W., Eller, J., & Schönfeldt‐Lecuona, C. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001600 · Cited by 14 · see citing works

Reliability and validity of the Severity of Dependence Scale in a Chinese sample of treatment-seeking ketamine users.

Tung, C.-K., Yeung, S. W., Chiang, T. P., Xu, K., & Lam, M. W. C. (2014) · PubMed · Cited by 14 · see citing works

Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology

Sinclair, J., Kalk, N. J., Kaar, S. J., Agabio, R., Arunogiri, S., Bisaga, A. M., Chesney, E., Daly, C., Dewhurst, J., Freeman, T. P., et al. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811251399593 · Cited by 8 · see citing works

Test-retest reliability and cross-cultural applicability of DSM-5 adopted diagnostic criteria for ketamine use disorders

Fitzgerald, N. D., Striley, C. W., Palamar, J. J., Copeland, J., Kurtz, S. P., & Cottler, L. B. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109056 · Cited by 8 · see citing works

“K-Powder” Exposure during Adolescence Elicits Psychiatric Disturbances Associated with Oxidative Stress in Female Rats

Cartágenes, S. D. C., da Silveira, C. C. S. D. M., Pinheiro, B. G., Fernandes, L. M. P., Farias, S. V., Kobayashi, N. H. C., de Souza, P. H. F. S., do Prado, A. F., Ferreira, M. K. M., Lima, R. R., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15111373 · Cited by 7 · see citing works

Sleep quality among individuals with ketamine use and the mediating role of craving

Yen, C., Lin, H., Ko, C., Wu, H., Hsu, C., & Wang, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-77631-9 · Cited by 7 · see citing works

Ketamine Abuse: Past and Present

Huang, M., & Lin, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-2902-3_1 · Cited by 8 · see citing works

Increased recreational ketamine use and subsequent outbreak of urological complications in The Netherlands

van Riel, A. J. H. P., van der Sanden, W. M. H., & de Kort, L. M. O. (2025) · Clinical Toxicology · doi:10.1080/15563650.2025.2513622 · Cited by 6 · see citing works

Withdrawal Assessment Following Subchronic Oral Ketamine Administration in Cynomolgus macaques

Walgren, J., Carfagna, M. A., Koger, D., Sgro, M. P., & Kallman, M. J. (2014) · Drug Development Research · doi:10.1002/ddr.21168 · Cited by 6 · see citing works

An Update of Ketamine Illicit Use

Kleczkowska, P., & Zaremba, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100644 · Cited by 5 · see citing works

Long-Term Intravenous Ketamine for Analgesia in a Child with Severe Chronic Intestinal Graft versus Host Disease

Busse, J. A., Phillips, L., & Schechter, W. S. (2015) · Case Reports in Anesthesiology · doi:10.1155/2015/834168 · Cited by 4 · see citing works

Ketamine Analgesia

Oudejans, L. C. J., van Velzen, M., & Dahan, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00050-9 · Cited by 4 · see citing works

Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study

Veraart, J. K. E., Vos, C. F., Punt, N. C., Visser, D., Wessels, A. M. A., Smith-Apeldoorn, S. Y., Kamphuis, J., Schoevers, R. A., & Touw, D. J. (2025) · Pharmaceuticals · doi:10.3390/ph18050627 · Cited by 2 · see citing works

A Roller Coaster from Methamphetamine to Ketamine

Huang, M., Lin, S., & Chen, C. (2014) · 臺灣精神醫學 · Cited by 2 · see citing works

Substance use disorders

Reid, A. G. (2016) · Medicine · doi:10.1016/j.mpmed.2016.09.013 · Cited by 2 · see citing works

Stimulant Drugs: Introduction

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.006 · Cited by 1 · see citing works

Grayken lessons: a multidisciplinary approach to care for a patient with severe ketamine use disorder

Appley, M., Gray, J. R., Abdulrahim, D., & Bowden‐Jones, O. (2026) · Addiction Science & Clinical Practice · doi:10.1186/s13722-026-00645-7 · Cited by 1 · see citing works

Intensive ketamine use for multiple years: A case report

Liu, J. X., Zerbo, E. A., & Ross, S. (2014) · American Journal on Addictions · doi:10.1002/ajad.12153.x · Cited by 1 · see citing works

Substance use disorders

Reid, A. G. (2012) · Medicine · doi:10.1016/j.mpmed.2012.09.020 · Cited by 1 · see citing works

Addictions and Substance Misuse

(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg004 · Cited by 1 · see citing works

Chronic effects of ketamine on gene expression changes in neurotransmitter receptors and regulators-A PCR-array study

Tan, S., Zou, J., Li, M., & Yew, D. T. W. (2015) · Molecular & Cellular Toxicology · doi:10.1007/s13273-015-0041-3

ACMDCouncil on the Misuse of Drugs

Sulaiman, Z., Street, M., & Featherstone, L. (2014)

Ketamine: The Glutamatergic Antidepressant and Its Efficacy

Tracy, D. K., Caddy, C., & Shergill, S. S. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_41

Modulação hormonal das alterações psicofisiológicas induzidas pelo uso crônico do anestésico dissociativo ketamina

Brasilino, L. S. B. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.59.2017.tde-11092017-221909

Alterações na dinâmica neural induzida pela preferência condicionada ao lugar de ratos previamente tratados com o anestésico dissociativo Ketamina

Prado, P. C. (2018) · doi:10.11606/d.59.2018.tde-05112017-222014

A cetamina associada ou não ao álcool, quais as consequências toxicológicas e sua influência no estresse oxidativo? Estudo em ratos

Mendes, P. F. (2019) · doi:10.11606/t.10.2019.tde-12122018-113556

Club Drugs and Novel Psychoactive Substances

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106

A Brief History of NPS Production and Distribution

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.003

Stimulant Drugs: Synthetic Cathinones

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.011

Stimulant Drugs: Methamphetamine

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.009

Classification Framework for Club Drugs and NPS

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.004

Stimulant Drugs: Amphetamine-Type Stimulants

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.008

Depressant Drugs: Gamma-Hydroxybutyrate (GHB) and Gamma-Butyrolactone (GBL)

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.013

The Clinical Challenge of Club Drugs and NPS

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.005

Depressant Drugs: Benzodiazepine NPS

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.015

Stimulant Drugs: Cocaine

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.007

Synthetic Cannabinoid Receptor Agonists (SCRAs)

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.017

Stimulant Drugs: MDMA and Drugs with Similar Effects

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.010

What Are Club Drugs and NPS and Why Are They Important?

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.002

Depressant Drugs: Fentanyl, Fentanyl Analogues and Other Opioid NPS

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.014

Concluding Remarks

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.019

Substance Misuse

Stark, M., & Norfolk, G. A. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-258-8_12

Depressant Drugs: Introduction

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.012

Depressant Drugs: Ketamine and Its Analogues

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.016

Introduction

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.001

Hallucinogens

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.018

Ketamine

Barceloux, D. G. (2012) · Wiley eBooks · doi:10.1002/9781118105955.ch7

Faculty Opinions recommendation of Attenuation of antidepressant effects of ketamine by opioid receptor antagonism.

Hen, R. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733878336.793552589

Index

Bowden‐Jones, O., & Abdulrahim, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623106.020

Addictions and Substance Misuse

(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg004.pub2

Chapter 9. Club Drugs and Inhalants

Rosenthal, R. N., & Tsoy-Podosenin, M. (2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550862.lg09

[A case of ketamine dependence].

Florkowski, A., & Ferfecki, L. (1988) · PubMed · Cited by 3 · see citing works

[Ketamine dependence].

Rusek, A., Matkowski, J., & Matysiakiewicz, J. A. (1988) · PubMed

Hallucinogen Persisting Perception Disorder Following Therapeutic Ketamine: A Case Report

Salzman, C., & Abraham, H. D. (2017) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000281 · Cited by 2 · see citing works

Ketamine Dependence: Case Report and Review

Sousa, A. D., Prabhu, A., & Matcheswalla, Y. (2010) · Journal of Pakistan Psychiatric Society

The use of ketamine in opioid withdrawal: case reports

Bachellier, J., Barrault, S., Ballon, N., Brunault, P., & Maugé, D. (2018) · HAL